After completing his PhD on gene regulation
in Germany in 1993, Thomas Grewal studied lipoprotein receptors during
postdoctoral fellowships at the Heart Research Institute (HRI, Sydney) and the
Clinical Research Institute (Montreal, Canada). From 1997–2003, Thomas Grewal
led a research group at the University Hospital Eppendorf (Hamburg, Germany)
and later (2003–2007) at the Centre for Immunology (CFI, St Vincent’s Hospital,
Sydney). Thomas Grewal joined the School of Pharmacy in October 2007. His research
examines the link between membrane transport and cell signaling, which
regulates spatiotemporal signaling in health and disease. Utilizing a
multi-disciplinary approach involving biochemistry, molecular cell biology, and
state-of-the-art microscopy, he has developed expertise in scaffolding proteins
and cellular cholesterol transport, which coordinates the localization/activity
of signaling complexes and receptors.
